Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For adults with autism:
- Adults who have been formally diagnosed with autism using an internationally recognised diagnostic system
- Currently receiving outpatient care at a specialised autism centre in the Netherlands
- Able to understand and engage with the topics that will be discussed in the study
- Willing and motivated to take part in research
For people close to someone with autism (such as family or support people):
- Adults who do not have a formal psychiatric diagnosis themselves
- Living in the Netherlands
- Able to understand and engage with the topics that will be discussed in the study
- Willing and motivated to take part in research
For healthcare providers:
- Practising psychiatrists, clinical psychologists, or nurse specialists working at an autism expertise centre in the Netherlands
- Living in the Netherlands
- Willing and motivated to take part in research
Who may not be able to join:
For adults with autism:
- People who do not have a good command of the Dutch language
- People who use alcohol or recreational drugs during the study period
- People whose mental health is considered too unstable to take part safely
- People who have prior experience with treatment through VGZ (a Dutch health insurance provider) (confirm with trial site)
For people close to someone with autism:
- People who do not have a good command of the Dutch language
- People who use alcohol or recreational drugs during the study period
For healthcare providers:
- People who do not have a good command of the Dutch language
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nynke Boonstra, Professor, UMC Utrecht
Phone: +31 6 20083507
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Developing an intervention using the Intervention Mapping method.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.